Pro Medicus Limited announced that it has received FDA clearance for its Breast Density AI Algorithm. This is in addition previously receiving CE clearance (Europe) and TGA clearance (Australia) paving the way for the company to market the algoritm across all three jurusdictions. The Breast Density algorithm is intended for use with compatible full field digital and digital breast tomosynthesis systems. It assesses breast density from a mammography study and provides an ACR BI-RADS Atlas 5th Edition breast density category to aid radiologists in the assessment of breast tissue composition.